Surgery to prevent lymphedema in breast cancer patients
Official title: Lymfo-Veneuse Anastomosen Ter Preventie Van Lymphoedeem
Run by University Hospital, Ghent · NCT05601037 · Data updated 2026-11-12
This study is testing whether a special surgery can help prevent lymphedema in breast cancer patients who are having their lymph nodes removed.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 99 Years |
| Sex | Women only |
| Enrollment | 80 (estimated) |
| Sponsor | University Hospital, Ghent Academic / other |
| Locations | 1 site (Ghent, Oost-Vlaanderen) |
| Status | Recruiting |
| Started | June 30, 2021 |
| Main results expected | December 27, 2025 |
| Study ends | December 27, 2026 |
| Registry record updated | November 8, 2024 |
| Trial ID | NCT05601037 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with breast cancer requiring axilla dissection and who have positive lymph nodes.
✕Probably not a fit
Patients with a history of lymphedema or a BMI greater than 35 may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of prophylactic lymphovenous anastomosis (LVA) in preventing lymphedema in patients undergoing axilla dissection for breast cancer treatment. It is a blinded randomized prospective study involving 80 patients, where one group will receive LVA during their surgery while the other group will receive standard care. Patients will be followed for two years to assess the outcomes related to lymphedema development.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the incidence of lymphedema in breast cancer patients post-surgery.
How similar studies have gone: While the concept of LVA is gaining traction, this specific approach is relatively novel and has not been extensively tested in similar studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * lymph node + breast cancer requiring dissection Exclusion Criteria: * previous lymphedema * BMI \>35
Where it's running
-
Uz Gent
Ghent, Oost-Vlaanderen, Belgium Recruiting
Study contacts
- Principal investigator: Bernard Depypere, MD — Uz Gent
- Study coordinator: Bernard Depypere, MD
- Email: bernard.depypere@ugent.be
- Phone: 093325730
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gentle Touch therapy for arm lymphedema after breast cancer surgery
We will test whether adding Gentle Touch lymphatic drainage to usual rehabilitation reduces arm swelling in women aged 30–75 with breast cancer–related lymphedema.
-
Comparing surgical and conservative treatments for chronic lymphedema after breast cancer
This study is testing whether surgery can help improve the quality of life for people with chronic lymphedema after breast cancer compared to just using physical therapy.
-
LYMPHA procedure to prevent arm lymphedema after axillary lymph node removal
This trial will try adding the LYMPHA lymphatic reconstruction at the time of axillary lymph node removal to see if it lowers the risk of lymphedema in adults having lymphadenectomy for breast cancer.
-
Dayspring wearable compression for breast cancer–related arm lymphedema after lymphatic surgery
This study will test whether the Dayspring wearable compression system helps move lymph and reduce arm swelling in adults with breast cancer–related lymphedema after lymphatic surgery.
-
ESWT added to standard lymphedema care for breast cancer patients
This study tests whether adding extracorporeal shock wave therapy to standard lymphedema care helps women with unilateral Stage II breast cancer–related swelling.
-
Pneumatic compression versus manual lymph drainage as part of decongestive care for breast cancer–related lymphedema
This study tests whether adding or replacing manual lymph drainage with intermittent pneumatic compression helps women with unilateral breast cancer–related arm lymphedema.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.